These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30189505)

  • 21. Concerns about pregabalin: further experience with its potential of causing addictive behaviors.
    Gahr M; Franke B; Freudenmann RW; Kölle MA; Schönfeldt-Lecuona C
    J Addict Med; 2013; 7(2):147-9. PubMed ID: 23519046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible heart failure exacerbation associated with pregabalin: case discussion and literature review.
    Page RL; Cantu M; Lindenfeld J; Hergott LJ; Lowes BD
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):922-5. PubMed ID: 18695430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Generalized anxiety disorder with comorbidity. Treatment with pregabalin].
    Lauer D; Hölzel L; Hornyak M
    Nervenarzt; 2006 Nov; 77(11):1363, 1365-7. PubMed ID: 16786360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential.
    Schjerning O; Pottegård A; Damkier P; Rosenzweig M; Nielsen J
    Pharmacopsychiatry; 2016 Jul; 49(4):155-61. PubMed ID: 26951495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin for the treatment of social anxiety disorder.
    Kawalec P; Cierniak A; Pilc A; Nowak G
    Expert Opin Investig Drugs; 2015 Apr; 24(4):585-94. PubMed ID: 25361817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment.
    Wettermark B; Brandt L; Kieler H; Bodén R
    Int J Clin Pract; 2014 Jan; 68(1):104-10. PubMed ID: 23815622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder.
    Boschen MJ
    Can J Psychiatry; 2011 Sep; 56(9):558-66. PubMed ID: 21959031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery.
    Gonano C; Latzke D; Sabeti-Aschraf M; Kettner SC; Chiari A; Gustorff B
    J Psychopharmacol; 2011 Feb; 25(2):249-53. PubMed ID: 19825903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregabalin--a drug with abuse potential?].
    Skopp G; Zimmer G
    Arch Kriminol; 2012; 229(1-2):44-54. PubMed ID: 22448469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin Abuse amongst Opioid Substitution Treatment Patients.
    McNamara S; Stokes S; Kilduff R; Shine A
    Ir Med J; 2015; 108(10):309-10. PubMed ID: 26817289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.
    Sun P; Peng X; Sun S; Novick D; Faries DE; Andrews JS; Wohlreich MM; Wu A
    Pain Pract; 2014 Jan; 14(1):22-31. PubMed ID: 23489659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.
    Roth T; Arnold LM; Garcia-Borreguero D; Resnick M; Clair AG
    Sleep Med Rev; 2014 Jun; 18(3):261-71. PubMed ID: 24119681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible heart failure associated with pregabalin use: case report.
    Erdoğan G; Ceyhan D; Güleç S
    Agri; 2011 Apr; 23(2):80-3. PubMed ID: 21644108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.
    Montgomery S; Chatamra K; Pauer L; Whalen E; Baldinetti F
    Br J Psychiatry; 2008 Nov; 193(5):389-94. PubMed ID: 18978320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.
    Schifano F; Chiappini S; Corkery JM; Guirguis A
    Brain Sci; 2018 Apr; 8(4):. PubMed ID: 29690558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
    Pande AC; Crockatt JG; Feltner DE; Janney CA; Smith WT; Weisler R; Londborg PD; Bielski RJ; Zimbroff DL; Davidson JR; Liu-Dumaw M
    Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.